Immune inactivation by neuropilin-1 predicts clinical outcome and therapeutic benefit in muscle-invasive bladder cancer.
Yu Y, Zeng H, Jin K, You R, Liu Z, Zhang H, Liu C, Su X, Yan S, Chang Y, Liu L, Xu L, Xu J, Zhu Y, Wang Z.
Yu Y, et al. Among authors: su x.
Cancer Immunol Immunother. 2022 Sep;71(9):2117-2126. doi: 10.1007/s00262-022-03153-0. Epub 2022 Jan 18.
Cancer Immunol Immunother. 2022.
PMID: 35041031
Free PMC article.